Donald Trump’s CIA pick Gina Haspel is career spymaster, oversaw secret prison

Agencies
March 14, 2018

Washington, Mar 14: President Donald Trump’s pick to be the next director of the CIA is a career spymaster who oversaw torture at a secret prison during one of the darkest chapters in the agency’s history. If confirmed, 61-year-old Gina Haspel would become the first female head of the CIA. She’s described by colleagues as a seasoned veteran with 30-plus years of intelligence experience who would lead the agency with integrity. But it’s the few years she spent supervising a secret black site that will be closely scrutinized at her confirmation hearing.

Trump announced on Tuesday that he had chosen Haspel to succeed Mike Pompeo, who is replacing ousted Secretary of State Rex Tillerson. She joined the CIA in 1985 and has been deputy director of the agency since February 2017.

Between 2003 and 2005, Haspel oversaw a secret CIA prison in Thailand where terror suspects Abu Zubayadah and Abd al Rahim al-Nashiri were waterboarded, current and former U.S. intelligence officials said. Waterboarding is a process that simulates drowning and is widely considered to be a form of torture. Haspel also helped carry out an order to destroy waterboarding videos, which prompted a lengthy Justice Department investigation that ended without charges.

Trump has said that he would reintroduce waterboarding and “a lot worse,” but there’s no indication that his decision to pick Haspel signals a desire to restart the harsh interrogation and detention program. He would face steep legal and legislative hurdles if he tried.

Sen. John McCain, R-Ariz., said Haspel must explain the nature and extent of her involvement in the CIA’s interrogation program. “Current U.S. law is clear in banning enhanced interrogation techniques,” said McCain, who was beaten as a prisoner during the Vietnam War. “Any nominee for director of the CIA must pledge without reservation to uphold this prohibition.”

Former CIA Director John Brennan declined to say what Haspel’s exact role was in the interrogation program, but he told NBC that she has a “lot of integrity” and has tried to carry out her agency duties “when asked to do difficult things in challenging times.”

Brennan predicted she would be confirmed. “Gina is a very competent professional who I think deserves the chance to take the seat,” he said. Senator Richard Burr, R-N.C., the chairman of the Senate intelligence committee, which will vote whether to confirm Haspel, said she has the “right skill set, experience and judgment” to lead the CIA.

Human rights advocates said they opposed Haspel’s promotion to the helm of the CIA. “No one who had a hand in torturing individuals deserves to ever hold public office again, let alone lead an agency,” Human Rights First’s Raha Wala said Tuesday. “To allow someone who had a direct hand in this illegal, immoral and counterproductive program is to willingly forget our nation’s dark history with torture.”

After Haspel was named deputy CIA director, the European Center for Constitutional and Human Rights asked German prosecutors to issue a warrant for her arrest over her role in the interrogations. Federal prosecutors never issued the warrant because the case lacked a connection to Germany. But the rights group’s allegations against Haspel remain part of a preliminary investigation that German authorities could revive if they receive evidence that any of the parties have links to Germany.

Last year, Haspel’s name came up during a civil lawsuit in Spokane, Washington, filed by three men who said they suffered waterboarding, beatings and sleep deprivation in the CIA interrogation program developed by former Spokane psychologists James E. Mitchell and Bruce Jessen.

Lawyers for the psychologists wanted to interview Haspel and another CIA official involved in the program, but government lawyers told the federal judge in the case that the officials and documents were protected under the state secrets privilege and making them public would threaten national security.

Haspel has been chief of station at CIA outposts abroad. In Washington, she has held several senior leadership positions, including deputy director of the National Clandestine Service.

In her current post, she worked with Pompeo to manage intelligence collection, analysis, covert action, counterintelligence and cooperation with the CIA’s foreign counterparts. In a brief statement, the former undercover officer said she was “humbled” by Trump’s confidence in her to lead the agency.

Comments

Linda Peters
 - 
Wednesday, 14 Mar 2018

I had ever read. I hope it will help a lot for all. Thank you so much for this amazing posts and keep update like this excellent article.

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Washington, Apr 24: The number of coronavirus cases in the US has surpassed 850,000, Johns Hopkins University Coronavirus Resource Center data revealed on Thursday (local time).
The country now has registered 8,56,209 cases overall, according to the data, including 47,272 deaths.

The US currently leads the world in the number of reported COVID-19 deaths and confirmed cases.

There are more than 2.6 million COVID-19 cases around the world and more than 1,85,000 deaths, according to the data.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 9,2020

Washington, Jul 9: The United States recorded 55,000 new coronavirus cases in 24 hours on Wednesday (Thursday in Malaysia), a tally by Johns Hopkins University showed, bringing its total to 3,046,351 recorded infections since the pandemic began.

The country, the hardest-hit in the world, had earlier on Wednesday passed the grim milestone of three million infections. The actual number is likely far higher due to issues over getting tested in March and April.

The US also added an additional 833 virus deaths, bringing the death toll to 132,195, the Baltimore-based institution showed at 8.30pm (0030 GMT Thursday).

US President Donald Trump regularly downplays the numbers, attributing them to an increase in testing capacity during the month of June.

Coronavirus cases are surging in several southern hotspots including Texas, Florida, Louisiana and Arizona, but the pandemic has almost entirely receded from its former epicentre in New York and the north-east.

Several states have been forced to suspend their reopening processes or even reverse course, with some ordering bars to close again.

On Wednesday morning, Trump called on schools throughout the country to reopen in the fall, lashing out at his own top health agency to ease health and safety requirements aimed at slowing the spread of the virus, such as social distancing.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.